ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,474,000 | -31.5% | 75,000 | 0.0% | 0.43% | -26.3% |
Q2 2018 | $2,152,000 | +82.1% | 75,000 | +50.0% | 0.58% | +77.1% |
Q1 2018 | $1,182,000 | -38.2% | 50,000 | -33.3% | 0.33% | +12.0% |
Q2 2016 | $1,913,000 | -71.1% | 75,000 | -70.0% | 0.29% | -66.6% |
Q1 2016 | $6,613,000 | +54.6% | 250,000 | +150.0% | 0.88% | +44.2% |
Q4 2015 | $4,278,000 | +193.4% | 100,000 | +81.8% | 0.61% | +228.1% |
Q3 2015 | $1,458,000 | -67.8% | 55,000 | -59.6% | 0.18% | -64.7% |
Q2 2015 | $4,533,000 | -35.1% | 136,000 | -35.2% | 0.52% | -28.5% |
Q1 2015 | $6,989,000 | – | 210,000 | – | 0.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |